TGTGInsighttelegram intelligenceLIVE / telegram public index
← () => "翠楼屋"

TGINSIGHT SIMILAR POSTS

查找相似内容

Source channel @lambdaexpression · Post #206 · 4月20日

前段时间一直被MajdataPlay的外键输入问题困扰:有玩家反映majplay会无征兆地出现拖判和吃音,但是内屏一切正常 因为我是第一次接触游戏开发,IO这方面也完全没经验 一开始我和bb本怀疑是线程调度的问题,即:IO线程时间片被其他线程挤占了,导致IO线程无法及时处理HID设备回报。为了验证这个猜想,我们尝试提高了IO线程的优先级,照旧 接下来我怀疑是我那套框架有问题:majplay是根据上一帧与这一帧的按键状态判断按键是不是"click"。为此我重写了这部分的实现,改进了IO线程与主线程之间的交互,问题照旧....... 到这里我已经怀疑这不是majplay的锅:IO线程没有任何异常,IO线程与主线程的交互没有问题,Note判定逻辑也没有问题,那就是设备确实没有回报给majplay或者设备发过来的回报中按键确实没有按下,但是大佬说hdd没有这种问题.....(人已经快崩溃了,这完全看不透也摸不着,因为我用单片机模拟玩家打高速纵连是完全没有问题的,我在家里用手台测试也没有问题) 到最后,bb本灵光一闪,说有没有可能是led刷新率过高,把按键控制板干爆炸了?我们让大佬把led刷新间隔从16ms改成100ms,吃音问题瞬间没有了,无语了 。。。。。。。。。。。。。。。。。。。。 adx是一个控制板同时管理按键和led,为什么我没有遇到吃音问题呢,因为我的手台不是adx的... #dev

Hashtags

Results

找到 1 条相似帖子

搜索 #bitdca

当前筛选 #bitdca清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #4251 · 2025/02/26 13:00

Recent Funding Rounds Overview 🔍Funding Highlights: - Edera: $15M on Feb 25, 2025. Secure products launch. Learn more - Zhongjiang Keyi: $13.83M on Feb 24, 2025. Nanjing's new material tech firm. Learn more - Cholesgen: $13.83M on Feb 24, 2025. Innovating biopharmaceuticals for chronic diseases. Learn more - Magdrive: $10.50M on Feb 25, 2025. High-power propulsion system for space. Learn more - Arsenale Bioyards: $10M on Feb 25, 2025. Economical biomanufacturing through precision fermentation. Learn more - Paradox Immunotherapeutics: $10M on Feb 25, 2025. Focused on rare disease treatments. Learn more - BitDCA: $7.99M on Feb 24, 2025. New cryptocurrency distribution method. Learn more - Dametis: $7.33M on Feb 21, 2025. Software for environmental performance challenges. Learn more - QT Sense: $6.29M on Feb 25, 2025. Quantum sensing tech for biomedical research. Learn more - Floodbase: $5M on Feb 20, 2025. AI platform for flood risk insurance. Learn more #Funding#Edera#ZhongjiangKeyi#Cholesgen#Magdrive#ArsenaleBioyards#ParadoxImmunotherapeutics#BitDCA#Dametis#QTSense#Floodbase#Biotech#AI#Crypto#SpaceTech#Pharma#Innovation#EnvironmentalTech#QuantumTech#Biomanufacturing#RiskManagement